Position in ARGX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$10,698,162
-$780,805 QoQ
Shares Held
14,650
+7.3% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
4.61%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DCF Advisers, LLC holds $55,922,160 across 20 Biotechnology names. ARGX ranks #1 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
14,650 | $10,698,162 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
637,500 | $9,326,625 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,250 | $7,146,920 | |
| 4 | NAMS |
NewAmsterdam Pharma Co N.V.
|
160,600 | $5,140,806 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
56,000 | $4,205,040 | |
| 6 | INCY |
Incyte Corp
|
41,500 | $3,905,980 | |
| 7 | HELP |
Cybin Inc.
|
691,988 | $3,321,542 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,000 | $3,125,780 |
All Filings in ARGX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,698,162 | 14,650 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $11,478,967 | 13,650 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $10,067,694 | 13,650 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,524,153 | 13,650 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,493,262 | 14,350 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $12,300,000 | 20,000 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $10,841,600 | 20,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,600,800 | 20,000 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,953,144 | 20,200 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,779,793 | 20,450 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $10,815,860 | 22,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,016,061 | 25,700 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $9,575,306 | 25,700 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,470,750 | 25,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,826,250 | 25,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,472,000 | 25,000 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,882,750 | 25,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,754,750 | 25,000 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $7,550,000 | 25,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,021,400 | 20,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,609,360 | 24,000 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $7,058,160 | 24,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,300,480 | 24,000 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,405,520 | 24,000 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,161,520 | 24,000 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||